Nature of Operations - Additional Information (Detail) (USD $)
|
12 Months Ended |
0 Months Ended |
|
|
|
|
Dec. 31, 2014
|
Apr. 11, 2014
|
Aug. 31, 2014
|
Dec. 31, 2013
|
Jun. 30, 2013
|
Oct. 31, 2009
|
Nature of Operations [Line Items] |
|
|
|
|
|
|
Number of common shares called by warrants |
33,333us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
|
162,539us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
301,778us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
301,778us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
27,839us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
Common stock, shares outstanding |
25,938,332us-gaap_CommonStockSharesOutstanding
|
|
|
6,964,788us-gaap_CommonStockSharesOutstanding
|
|
|
Private placement of equity, net proceeds |
$ 8,402,000us-gaap_ProceedsFromIssuanceOfPrivatePlacement
|
|
|
|
|
|
JB Therapeutics Inc. [Member] |
|
|
|
|
|
|
Nature of Operations [Line Items] |
|
|
|
|
|
|
Conversion of stock, shares issued |
|
9,000,000us-gaap_ConversionOfStockSharesIssued1 / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember
|
|
|
|
|
Number of shares converted to common stock |
|
5,964,649us-gaap_ConversionOfStockSharesConverted1 / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember
|
|
|
|
|
Number of common shares called by warrants |
|
377,839us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember
|
|
|
|
|
Number of options to purchase shares of common stock |
|
905,334crbp_OptionToPurchaseCommonStockShares / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember
|
|
|
|
|
Exchange ratio of shares |
1.5089crbp_CommonStockExchangeRatio / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember
|
|
|
1.5089crbp_CommonStockExchangeRatio / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember
|
|
|
Common stock, shares outstanding |
|
6,000,000us-gaap_CommonStockSharesOutstanding / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember
|
|
|
|
|
Series A Preferred Stock [Member] | JB Therapeutics Inc. [Member] |
|
|
|
|
|
|
Nature of Operations [Line Items] |
|
|
|
|
|
|
Number of common shares called by warrants |
|
917,612us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember / us-gaap_StatementClassOfStockAxis = us-gaap_SeriesAPreferredStockMember
|
|
|
|
|
Minimum [Member] | JB Therapeutics Inc. [Member] |
|
|
|
|
|
|
Nature of Operations [Line Items] |
|
|
|
|
|
|
Common stock warrants, exercise price |
|
0.60us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember / us-gaap_RangeAxis = us-gaap_MinimumMember
|
|
|
|
|
Options exercise price |
|
0.11crbp_ExercisePriceOfOption / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember / us-gaap_RangeAxis = us-gaap_MinimumMember
|
|
|
|
|
Maximum [Member] | JB Therapeutics Inc. [Member] |
|
|
|
|
|
|
Nature of Operations [Line Items] |
|
|
|
|
|
|
Common stock warrants, exercise price |
|
0.66us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember / us-gaap_RangeAxis = us-gaap_MaximumMember
|
|
|
|
|
Options exercise price |
|
0.17crbp_ExercisePriceOfOption / us-gaap_BusinessAcquisitionAxis = crbp_JbTherapeuticsIncMember / us-gaap_RangeAxis = us-gaap_MaximumMember
|
|
|
|
|